AbbVie Inc. (ABBV)
25 filings available.
Loading activity recap...
Loading insider activity...
Loading institutional activity...
Loading fund comparison...
Loading contract awards...
Loading activity heatmap...
Full Timeline
Every tracked SEC filing, congressional trade, 13F/N-PORT holding change, lobbying disclosure, government contract award, SEC enforcement action, and pay-vs-performance filing for ABBV, merged into one feed.
Loading timeline...
Get instant alerts the moment ABBV files, trades, or shows up in Congress, 13F, or lobbying data — right on your phone.
Get the app →Recent filings
- AbbVie Reports $216M Acquired IPR&D Expense and Updates 2026 EPS Guidance8-KOct 5, 2026
- AbbVie Director Susan E. Quaggin Acquires Stock Equivalent Units via Fee Deferral4Oct 2, 2026Filed by Quaggin Susan EAward / Fee Deferral · 59 shares · $15K